Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Rheumatoid Arthritis

Free Subscription Articles published in Scand J Rheumatol Retrieve available abstracts of 60 articles: HTML format

Single Articles

November 2025
1. VAN DONGEN JM, Bernaers L, Wagenaar CA, van der Leeden M, et al
   A multidisciplinary lifestyle programme for patients with rheumatoid arthritis and metabolic syndrome-associated osteoarthritis: economic evaluation alongside the 'Plants for Joints' randomized controlled trials.
   Scand J Rheumatol. 2025 Nov 10:1-14. doi: 10.1080/03009742.2025.2550133.
   PubMed     Abstract available
   
   
   
2. PUGLIESI A, Nourani H, Pires LC, Hotta LH, et al
   Myocardial strain in rheumatoid arthritis without traditional cardiovascular risk factors: an exploratory analysis.
   Scand J Rheumatol. 2025 Nov 6:1-3. doi: 10.1080/03009742.2025.2576966.
   PubMed    
   
   
   October 2025
3. DAMGAARD AJ, Mogard E, Primdahl J, Bremander A, et al
   Validity and reliability of the Danish and Swedish versions of the Bristol Rheumatoid Arthritis Fatigue Questionnaires in patients with spondyloarthritis.
   Scand J Rheumatol. 2025 Oct 8:1-13. doi: 10.1080/03009742.2025.2515689.
   PubMed     Abstract available
   
   
   
4. DING K, Jiang W, Yao H, Gao Y, et al
   Unravelling rheumatoid arthritis-related sarcopenia: animal models, pathogenesis, and anti-sarcopenia preclinical therapy.
   Scand J Rheumatol. 2025 Oct 8:1-14. doi: 10.1080/03009742.2025.2549613.
   PubMed     Abstract available
   
   
   September 2025
5. IKDAHL E, Mangseth H
   Are we screening effectively? A systematic review and meta-analysis of proposed risk factors for rheumatoid arthritis-associated interstitial lung disease screening.
   Scand J Rheumatol. 2025 Sep 9:1-9. doi: 10.1080/03009742.2025.2538946.
   PubMed     Abstract available
   
   
   
6. CHENG L, Jia L, Zhao G, Lin X, et al
   Rheumatoid arthritis complicated by sacroiliac joint infection: a case report.
   Scand J Rheumatol. 2025 Sep 1:1-3. doi: 10.1080/03009742.2025.2540169.
   PubMed    
   
   
   August 2025
7. TAN YK, Conaghan PG
   Understanding the use of thermography and its ability to predict ultrasound-detected joint inflammation at the metacarpophalangeal joint in patients with rheumatoid arthritis.
   Scand J Rheumatol. 2025 Aug 29:1-5. doi: 10.1080/03009742.2025.2548061.
   PubMed     Abstract available
   
   
   
8. SKIELTA M, Soderstrom L, Rantapaa-Dahlqvist S, Sodergren A, et al
   Is there an association between anti-inflammatory medical treatments for rheumatoid arthritis and mortality after first myocardial infarction?
   Scand J Rheumatol. 2025 Aug 29:1-7. doi: 10.1080/03009742.2025.2544409.
   PubMed     Abstract available
   
   
   
9. REN J, Li R, Peng H
   The relationship between arthritis or rheumatoid arthritis in the elderly and falls: results based on the China Health and Retirement Longitudinal Study (CHARLS).
   Scand J Rheumatol. 2025 Aug 11:1-4. doi: 10.1080/03009742.2025.2518630.
   PubMed    
   
   
   June 2025
10. SANDSTROM T, Kaipiainen-Seppanen O, Mali M, Kauppi M, et al
    Limited reduction of bone mineral density in patients with early rheumatoid arthritis receiving aggressive treatment: 10 year results of the NEO-RACo study.
    Scand J Rheumatol. 2025 Jun 23:1-9. doi: 10.1080/03009742.2025.2515696.
    PubMed     Abstract available
    
    
    
11. KODISHALA C, Jose George R, Javed R, Lovering EJ, et al
    Role of rheumatoid arthritis flare in the risk of Alzheimer's disease and related dementias: a population-based cohort study.
    Scand J Rheumatol. 2025 Jun 3:1-8. doi: 10.1080/03009742.2025.2503055.
    PubMed     Abstract available
    
    
    
12. HYLDGAARD C, Pedersen AR, Ellingsen T, Bendstrup E, et al
    Pulmonary function trajectories in rheumatoid arthritis-associated interstitial lung disease.
    Scand J Rheumatol. 2025 Jun 3:1-7. doi: 10.1080/03009742.2025.2503054.
    PubMed     Abstract available
    
    
    May 2025
13. LING SF, Ho P, Bukhari M, Mewar D, et al
    Pretreatment absolute monocyte counts are associated with biological disease-modifying anti-rheumatic drug non-response in patients with rheumatoid arthritis.
    Scand J Rheumatol. 2025 May 21:1-6. doi: 10.1080/03009742.2025.2497606.
    PubMed     Abstract available
    
    
    
14. LI CH, Gao JL, Ren C, Yang SM, et al
    Synovial chondromatosis in a patient with atypical rheumatoid arthritis confirmed by clinical, radiographic, and pathological evidence: a case report.
    Scand J Rheumatol. 2025 May 9:1-3. doi: 10.1080/03009742.2025.2491181.
    PubMed    
    
    
    
15. NANJAIAH H, Moudgil KD
    Pristimerin inhibits the progression of antibody-induced autoimmune arthritis.
    Scand J Rheumatol. 2025;54:198-203.
    PubMed     Abstract available
    
    
    April 2025
16. SAKELLARIOU GT, Chaitidis N, Katsigianni I, Tsifountoudis I, et al
    A patient with multiple sclerosis successfully treated with tofacitinib for rheumatoid arthritis.
    Scand J Rheumatol. 2025 Apr 1:1-3. doi: 10.1080/03009742.2025.2463733.
    PubMed    
    
    
    March 2025
17. LAURIDSEN KB, Duch KS, Mortensen AS, Cordtz R, et al
    Sex differences in treatment response in patients with rheumatoid arthritis treated with tumour necrosis factor inhibitor: a cohort study from the DANBIO registry.
    Scand J Rheumatol. 2025 Mar 20:1-11. doi: 10.1080/03009742.2025.2471713.
    PubMed     Abstract available
    
    
    February 2025
18. PEDERSEN SD, Nielsen BD, Assmann ML, Hauge EM, et al
    Early diagnosis of rheumatoid arthritis: associations between patients' perceptions of initial symptoms and the timing of seeking help from the general practitioner.
    Scand J Rheumatol. 2025 Feb 27:1-10. doi: 10.1080/03009742.2025.2464457.
    PubMed     Abstract available
    
    
    
19. KNUDSEN LR, Knitza J, Muhlensiepen F, Hueber A, et al
    Development and validation of a patient knowledge questionnaire for rheumatoid arthritis (PKQ-RA-11) in Danish and German.
    Scand J Rheumatol. 2025 Feb 24:1-9. doi: 10.1080/03009742.2025.2463734.
    PubMed     Abstract available
    
    
    
20. NAKAGOMI D, Hanai S
    Rapid improvement of rheumatoid arthritis symptoms with ozoralizumab: a case of progress monitored by musculoskeletal ultrasonography.
    Scand J Rheumatol. 2025 Feb 19:1-2. doi: 10.1080/03009742.2025.2464451.
    PubMed    
    
    
    
21. ACAR EA, Uslu S, Soysal Gunduz O, Pirildar T, et al
    'Pencil-in-cup' deformity in systemic sclerosis-rheumatoid arthritis overlap syndrome.
    Scand J Rheumatol. 2025 Feb 11:1-3. doi: 10.1080/03009742.2025.2456323.
    PubMed    
    
    
    
22. FUKUI S, Tawakol A, Winkelmayer WC, Santacroce LM, et al
    No association between vascular inflammation and estimated glomerular filtration rate in patients with rheumatoid arthritis: secondary analysis of the TARGET trial.
    Scand J Rheumatol. 2025 Feb 5:1-4. doi: 10.1080/03009742.2025.2455878.
    PubMed    
    
    
    
23. BAKKER NF, Knoop J, Schoones JW, Vliet Vlieland T, et al
    Work in the picture? The reporting of and effects on work outcomes in exercise therapy trials in people with rheumatoid arthritis or axial spondyloarthritis: a systematic review.
    Scand J Rheumatol. 2025 Feb 4:1-17. doi: 10.1080/03009742.2024.2445940.
    PubMed     Abstract available
    
    
    January 2025
24. HUPER S, Nagler L, Strunz PP, Froehlich M, et al
    Lymphoma in Sjogren's syndrome: no need for repetitive screening ultrasounds of the major salivary glands and neck in asymptomatic patients.
    Scand J Rheumatol. 2025;54:49-57.
    PubMed     Abstract available
    
    
    
25. LOFFLER C, Leipe J, Hellmich B
    Ultrasonographic findings in diabetic cheiroarthropathy: a pilot study.
    Scand J Rheumatol. 2025;54:41-48.
    PubMed     Abstract available
    
    
    
26. JORGENSEN TS, Hansen RL, Pouls B, Van den Bemt B, et al
    Retention rate of a novel autoinjector e-Device introduced to patients with chronic arthritis treated with certolizumab pegol in clinical practice: an observational implementation study.
    Scand J Rheumatol. 2025;54:25-32.
    PubMed     Abstract available
    
    
    November 2024
27. RASMUSSEN C, Can G, Steffensen R, Kenar Artin G, et al
    Incident rheumatoid arthritis in patients living in Turkey and in Denmark: a comparative clinical, genetic, and serological study.
    Scand J Rheumatol. 2024 Nov 25:1-8. doi: 10.1080/03009742.2024.2424083.
    PubMed     Abstract available
    
    
    
28. LIU T, Wang M, Li L, Wu T, et al
    Mitophagy drives maldifferentiation of tissue-resident memory T cells in patients with rheumatoid arthritis.
    Scand J Rheumatol. 2024 Nov 15:1-10. doi: 10.1080/03009742.2024.2420432.
    PubMed     Abstract available
    
    
    
29. PALSSON O, Love TJ, Wallman JK, Kapetanovic MC, et al
    Prescription of non-steroidal anti-inflammatory drugs for patients with inflammatory arthritis decreases with the initiation of tumour necrosis factor inhibitor therapy: results from the ICEBIO registry.
    Scand J Rheumatol. 2024;53:402-408.
    PubMed     Abstract available
    
    
    October 2024
30. VAN DEN DIKKENBERG M, Kuijper TM, Kok MR, Lopes Barreto D, et al
    Remote patient-reported outcome measure triage score for monitoring disease activity and allocation of consultations in rheumatoid arthritis patients.
    Scand J Rheumatol. 2024 Oct 30:1-8. doi: 10.1080/03009742.2024.2406611.
    PubMed     Abstract available
    
    
    
31. COLMENARES V, Hedman A, Hesslow A, Wahlin B, et al
    Cohort study of serological biomarkers for interstitial lung disease in patients with rheumatoid arthritis.
    Scand J Rheumatol. 2024 Oct 25:1-10. doi: 10.1080/03009742.2024.2413238.
    PubMed     Abstract available
    
    
    
32. HYLDGAARD C, Blegvad J, Sofiudottir BK, Andersen FD, et al
    Risk profiles for rheumatoid arthritis-associated interstitial lung disease in a cohort of patients with five-year follow-up.
    Scand J Rheumatol. 2024 Oct 24:1-6. doi: 10.1080/03009742.2024.2408867.
    PubMed     Abstract available
    
    
    
33. TEUWEN M, van Weely S, van den Ende C, van Wissen M, et al
    Cost-utility analysis of longstanding exercise therapy versus usual care in people with rheumatoid arthritis and severe functional limitations.
    Scand J Rheumatol. 2024 Oct 1:1-11. doi: 10.1080/03009742.2024.2392360.
    PubMed     Abstract available
    
    
    September 2024
34. ANDERSEN BB, Greisen S, Stengaard-Pedersen K, Junker P, et al
    Plasma haem oxygenase-1 may represent a first-in-class biomarker of oxidative stress in rheumatoid arthritis.
    Scand J Rheumatol. 2024 Sep 17:1-5. doi: 10.1080/03009742.2024.2392364.
    PubMed     Abstract available
    
    
    
35. TAKATANI A, Kobayashi T, Iwamoto N, Aramaki T, et al
    Methotrexate prolonged the shedding of replicable SARS-CoV-2 with re-increased antigens in a rheumatoid arthritis patient.
    Scand J Rheumatol. 2024 Sep 4:1-3. doi: 10.1080/03009742.2024.2361994.
    PubMed    
    
    
    
36. ZHU F, Zhang Y
    Rheumatoid arthritis with rice bodies bursitis.
    Scand J Rheumatol. 2024;53:359-360.
    PubMed    
    
    
    
37. SOKKA-ISLER T, Paalanen K, Puolakka K
    Keep a closer eye on 'seronegative rheumatoid arthritis'.
    Scand J Rheumatol. 2024;53:293-294.
    PubMed    
    
    
    August 2024
38. TICHY S, Nekvindova L, Baranova J, Vencovsky J, et al
    Drug survival analysis of etanercept compared with monoclonal antibody tumour necrosis factor-alpha inhibitors in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a propensity score-matched analysis from the Czech ATTRA registry.
    Scand J Rheumatol. 2024 Aug 6:1-8. doi: 10.1080/03009742.2024.2381746.
    PubMed     Abstract available
    
    
    July 2024
39. EKICI M, Baytar Y, Akdogan A, Durhan G, et al
    Prognostic factors for interstitial lung disease progression in rheumatoid arthritis: May methotrexate protect against progression?
    Scand J Rheumatol. 2024 Jul 25:1-9. doi: 10.1080/03009742.2024.2371658.
    PubMed     Abstract available
    
    
    
40. SOUSSI BG, Cordtz RL, Duch K, Kristensen S, et al
    Incidence of seropositive and seronegative rheumatoid arthritis in Denmark: a nationwide population-based study.
    Scand J Rheumatol. 2024 Jul 8:1-9. doi: 10.1080/03009742.2024.2365540.
    PubMed     Abstract available
    
    
    
41. TESTA D, Bilia S, Tavoni AG, Migliorini P, et al
    Adult-onset Still's disease: analysis of a monocentric cohort of patients.
    Scand J Rheumatol. 2024;53:263-268.
    PubMed     Abstract available
    
    
    
42. AYANO M, Tsubouchi K, Suzuki K, Kimoto Y, et al
    Comparing the safety and efficacy of nintedanib starting dose in patients with connective tissue disease-associated interstitial lung diseases.
    Scand J Rheumatol. 2024;53:255-262.
    PubMed     Abstract available
    
    
    
43. YOSHIHARA R, Tsuchiya H, Shoda H, Fujio K, et al
    Relationship between earlier introduction of tocilizumab and glucocorticoid-sparing effects on the acute phase of adult-onset Still's disease.
    Scand J Rheumatol. 2024;53:284-287.
    PubMed    
    
    
    June 2024
44. FARINA N, Tomelleri A, Boffini N, Cariddi A, et al
    Retention rates of different Janus kinase inhibitors in rheumatoid arthritis: experience from a large monocentric cohort.
    Scand J Rheumatol. 2024 Jun 4:1-5. doi: 10.1080/03009742.2024.2353433.
    PubMed     Abstract available
    
    
    May 2024
45. PROVAN SA, Ahlfors F, Bakland G, Hu Y, et al
    A validation of register-derived diagnoses of interstitial lung disease in patients with inflammatory arthritis: data from the NOR-DMARD study.
    Scand J Rheumatol. 2024;53:173-179.
    PubMed     Abstract available
    
    
    
46. GERTEL S, Rokach M, Polachek A, Litinsky I, et al
    Anti-inflammatory effects of infliximab and methotrexate on peripheral blood and synovial fluid mononuclear cells: ex vivo study.
    Scand J Rheumatol. 2024;53:188-198.
    PubMed     Abstract available
    
    
    April 2024
47. LI Z, Lei S, Zhou S, Zhang Z, et al
    Rheumatoid arthritis with chylothorax: a case report.
    Scand J Rheumatol. 2024 Apr 30:1-2. doi: 10.1080/03009742.2024.2342053.
    PubMed    
    
    
    March 2024
48. AHAMMAR S, Martinsson K, Ziegelasch M, Kastbom A, et al
    Prognostic value of serum protein electrophoresis constituents for arthritis development in anti-citrullinated protein antibody-positive patients with musculoskeletal pain.
    Scand J Rheumatol. 2024;53:118-122.
    PubMed     Abstract available
    
    
    February 2024
49. WANG J, Vordenbaumen S, Schneider M, Brinks R, et al
    Population-based epidemiological projections of rheumatoid arthritis in Germany until 2040.
    Scand J Rheumatol. 2024 Feb 15:1-12. doi: 10.1080/03009742.2024.2312693.
    PubMed     Abstract available
    
    
    January 2024
50. HOUGE IS, Hoff M, Videm V
    Self-determined motivation and physical activity in patients with rheumatoid arthritis: a cross-sectional study.
    Scand J Rheumatol. 2024 Jan 26:1-9. doi: 10.1080/03009742.2023.2300576.
    PubMed     Abstract available
    
    
    
51. YOO WH, Ha GW, Kim KM, Choi Y, et al
    When treatment takes a turn: tocilizumab-induced bowel perforation in a patient with COVID-19-afflicted rheumatoid arthritis.
    Scand J Rheumatol. 2024 Jan 10:1-3. doi: 10.1080/03009742.2023.2294580.
    PubMed    
    
    
    
52. ROGIND SS, Hetland ML
    Delayed identification of disseminated infection in a patient with rheumatoid arthritis and septic arthritis: a case report.
    Scand J Rheumatol. 2024;53:72-73.
    PubMed    
    
    
    December 2023
53. MICHITSUJI T, Fukui S, Morimoto S, Endo Y, et al
    Clinical and ultrasound features of difficult-to-treat rheumatoid arthritis: A multicenter RA ultrasound cohort study.
    Scand J Rheumatol. 2023 Dec 12:1-7. doi: 10.1080/03009742.2023.2277542.
    PubMed     Abstract available
    
    
    November 2023
54. KOMAI T, Sawada T, Tsuchiya H, Harada H, et al
    Resolution of exacerbated rheumatoid arthritis-associated interstitial lung disease under baricitinib treatment.
    Scand J Rheumatol. 2023 Nov 30:1-3. doi: 10.1080/03009742.2023.2274707.
    PubMed    
    
    
    
55. VAN WISSEN M, Straathof B, Vliet Vlieland T, van den Ende C, et al
    Construct validity of the PROMIS PF-10 in patients with inflammatory rheumatic diseases and severe limitations in physical functioning.
    Scand J Rheumatol. 2023;52:645-653.
    PubMed     Abstract available
    
    
    
56. ZENG M, Issotina Zibrila A, Li X, Liu X, et al
    Pyridostigmine ameliorates pristane-induced arthritis symptoms in Dark Agouti rats.
    Scand J Rheumatol. 2023;52:627-636.
    PubMed     Abstract available
    
    
    October 2023
57. BELAU MH, Flasskamp F, Becher H, Hajek A, et al
    Physical activity in adults with and without rheumatoid arthritis: cross-sectional results from the Survey of Health, Ageing and Retirement in Europe (SHARE).
    Scand J Rheumatol. 2023 Oct 31:1-6. doi: 10.1080/03009742.2023.2269672.
    PubMed     Abstract available
    
    
    September 2023
58. ZHANG Y, Zhu F, Liu C, Wang M, et al
    A case report of Sjogren's syndrome complicated with immune-mediated necrotizing myopathy.
    Scand J Rheumatol. 2023;52:580-583.
    PubMed    
    
    
    
59. UHRENHOLT L, Christensen R, Dreyer L, Hauge EM, et al
    Disease activity-guided tapering of biologics in patients with inflammatory arthritis: a pragmatic, randomized, open-label, equivalence trial.
    Scand J Rheumatol. 2023;52:481-492.
    PubMed     Abstract available
    
    
    
60. PFEIFFER-JENSEN M, Liao D, Tarp U, Deleuran B, et al
    Reduced prescription of TNF-inhibitors in chronic arthritis based on therapeutic drug monitoring: A randomized controlled trial.
    Scand J Rheumatol. 2023;52:468-480.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.